Loading viewer...
investor_presentation
Format: PDF investor_presentation
Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing genetically targeted therapies for alcohol use disorder. The company is advancing Phase 3 clinical programs aimed at driving innovation in addiction treatment and addressing unmet medical needs in alcohol addiction prevention and management.
Diana Biopharmaceuticals Investor Presentation 2021
investor_presentation
40 Pages
Diana Biopharmaceuticals
investor_presentation
TOMRA Systems ASA